Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 9 | 2024 | 889 | 2.220 |
Why?
|
| Heart Failure | 15 | 2024 | 2440 | 1.620 |
Why?
|
| Heart-Assist Devices | 11 | 2025 | 1101 | 1.260 |
Why?
|
| Heart Ventricles | 3 | 2020 | 804 | 0.900 |
Why?
|
| Infant, Premature | 5 | 2019 | 857 | 0.900 |
Why?
|
| Echocardiography | 9 | 2020 | 1132 | 0.770 |
Why?
|
| Transplants | 1 | 2022 | 37 | 0.730 |
Why?
|
| Ventricular Function, Left | 4 | 2022 | 556 | 0.590 |
Why?
|
| Acute Kidney Injury | 2 | 2023 | 704 | 0.560 |
Why?
|
| Heart Defects, Congenital | 3 | 2024 | 1885 | 0.550 |
Why?
|
| Hypertension, Pulmonary | 5 | 2020 | 475 | 0.540 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2018 | 114 | 0.540 |
Why?
|
| Thrombosis | 2 | 2022 | 547 | 0.530 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 176 | 0.510 |
Why?
|
| Retrospective Studies | 24 | 2025 | 17591 | 0.500 |
Why?
|
| Rhabdomyoma | 1 | 2015 | 16 | 0.490 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 575 | 0.490 |
Why?
|
| Everolimus | 1 | 2015 | 51 | 0.480 |
Why?
|
| Carotid Arteries | 1 | 2015 | 150 | 0.460 |
Why?
|
| Heart Neoplasms | 1 | 2015 | 106 | 0.450 |
Why?
|
| Pulmonary Artery | 4 | 2019 | 468 | 0.440 |
Why?
|
| Cardiac Catheterization | 3 | 2023 | 669 | 0.430 |
Why?
|
| Catheterization, Peripheral | 1 | 2015 | 132 | 0.430 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 906 | 0.420 |
Why?
|
| Cardiomyopathies | 3 | 2023 | 519 | 0.420 |
Why?
|
| Risk Assessment | 2 | 2019 | 3754 | 0.390 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1122 | 0.380 |
Why?
|
| Infant, Newborn | 12 | 2021 | 8640 | 0.380 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2020 | 211 | 0.380 |
Why?
|
| Infant | 16 | 2025 | 13263 | 0.350 |
Why?
|
| Child | 23 | 2025 | 25917 | 0.340 |
Why?
|
| Treatment Outcome | 13 | 2025 | 13105 | 0.340 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 1854 | 0.340 |
Why?
|
| Pulmonary Circulation | 4 | 2019 | 122 | 0.340 |
Why?
|
| Graft Survival | 2 | 2021 | 482 | 0.310 |
Why?
|
| Male | 22 | 2025 | 66215 | 0.300 |
Why?
|
| Nephrotic Syndrome | 1 | 2009 | 52 | 0.300 |
Why?
|
| Cyclosporine | 1 | 2009 | 128 | 0.290 |
Why?
|
| Adolescent | 12 | 2025 | 20647 | 0.290 |
Why?
|
| Female | 23 | 2025 | 72054 | 0.290 |
Why?
|
| Tacrolimus | 1 | 2009 | 107 | 0.290 |
Why?
|
| Drug Resistance | 1 | 2009 | 264 | 0.290 |
Why?
|
| Humans | 37 | 2025 | 134225 | 0.280 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2019 | 80 | 0.280 |
Why?
|
| Glomerular Filtration Rate | 2 | 2021 | 543 | 0.270 |
Why?
|
| Ventricular Function, Right | 2 | 2018 | 123 | 0.270 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2018 | 51 | 0.260 |
Why?
|
| Survival Rate | 3 | 2021 | 2214 | 0.260 |
Why?
|
| Blood Flow Velocity | 2 | 2019 | 466 | 0.250 |
Why?
|
| Glucocorticoids | 1 | 2009 | 401 | 0.250 |
Why?
|
| Child, Preschool | 10 | 2025 | 14897 | 0.230 |
Why?
|
| Logistic Models | 2 | 2021 | 1909 | 0.230 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 680 | 0.220 |
Why?
|
| Methylprednisolone | 1 | 2025 | 100 | 0.220 |
Why?
|
| Registries | 2 | 2021 | 1588 | 0.210 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2023 | 22 | 0.210 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 2 | 2022 | 32 | 0.200 |
Why?
|
| Vascular Resistance | 3 | 2019 | 203 | 0.200 |
Why?
|
| Prognosis | 4 | 2020 | 5085 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 316 | 0.190 |
Why?
|
| Shock, Cardiogenic | 1 | 2024 | 212 | 0.190 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 79 | 0.180 |
Why?
|
| Heart Failure, Systolic | 1 | 2021 | 36 | 0.180 |
Why?
|
| Graft Rejection | 2 | 2023 | 568 | 0.170 |
Why?
|
| Heart Valve Diseases | 1 | 2021 | 181 | 0.160 |
Why?
|
| Blood Pressure Determination | 2 | 2019 | 116 | 0.160 |
Why?
|
| Follow-Up Studies | 4 | 2024 | 5466 | 0.160 |
Why?
|
| Risk Factors | 5 | 2024 | 11196 | 0.150 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2021 | 145 | 0.150 |
Why?
|
| Probability | 1 | 2019 | 334 | 0.150 |
Why?
|
| Cohort Studies | 4 | 2021 | 5225 | 0.150 |
Why?
|
| Bilirubin | 1 | 2019 | 131 | 0.150 |
Why?
|
| Overweight | 1 | 2021 | 387 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 1144 | 0.150 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 191 | 0.150 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2020 | 148 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2023 | 523 | 0.140 |
Why?
|
| Obesity | 3 | 2021 | 2449 | 0.140 |
Why?
|
| Transplant Recipients | 1 | 2019 | 227 | 0.140 |
Why?
|
| Pregnancy in Diabetics | 1 | 2017 | 19 | 0.140 |
Why?
|
| Anticoagulants | 2 | 2022 | 626 | 0.130 |
Why?
|
| Inflammation | 1 | 2025 | 1595 | 0.130 |
Why?
|
| Infant, Premature, Diseases | 1 | 2019 | 254 | 0.130 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2016 | 52 | 0.130 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 500 | 0.130 |
Why?
|
| Nitric Oxide | 1 | 2019 | 487 | 0.130 |
Why?
|
| Kearns-Sayre Syndrome | 1 | 2016 | 6 | 0.130 |
Why?
|
| Cardiac Catheters | 1 | 2015 | 10 | 0.120 |
Why?
|
| Oxygen | 1 | 2019 | 580 | 0.120 |
Why?
|
| Balloon Valvuloplasty | 1 | 2015 | 25 | 0.120 |
Why?
|
| Reference Values | 1 | 2017 | 738 | 0.120 |
Why?
|
| Echocardiography, Doppler | 1 | 2016 | 174 | 0.120 |
Why?
|
| Punctures | 1 | 2015 | 63 | 0.120 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 1486 | 0.120 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2019 | 648 | 0.120 |
Why?
|
| Vascular Patency | 1 | 2015 | 198 | 0.120 |
Why?
|
| Prosthesis Design | 1 | 2018 | 664 | 0.120 |
Why?
|
| Time Factors | 5 | 2024 | 6595 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 808 | 0.110 |
Why?
|
| Young Adult | 7 | 2024 | 9963 | 0.110 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 243 | 0.110 |
Why?
|
| Prospective Studies | 4 | 2019 | 6617 | 0.110 |
Why?
|
| Renal Dialysis | 1 | 2021 | 893 | 0.110 |
Why?
|
| Angioplasty, Balloon | 1 | 2015 | 162 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2016 | 217 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 1493 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 382 | 0.110 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 544 | 0.110 |
Why?
|
| Tooth Discoloration | 1 | 2013 | 1 | 0.110 |
Why?
|
| Postmortem Changes | 1 | 2013 | 13 | 0.110 |
Why?
|
| Lipids | 1 | 2017 | 565 | 0.110 |
Why?
|
| Gestational Age | 1 | 2017 | 1230 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2017 | 1196 | 0.100 |
Why?
|
| Biopsy | 2 | 2023 | 1303 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2319 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 3119 | 0.090 |
Why?
|
| Hemodynamics | 3 | 2022 | 871 | 0.090 |
Why?
|
| Myocardium | 1 | 2016 | 1041 | 0.080 |
Why?
|
| Stents | 1 | 2015 | 881 | 0.080 |
Why?
|
| Stroke | 1 | 2018 | 1079 | 0.080 |
Why?
|
| Adult | 7 | 2024 | 31962 | 0.080 |
Why?
|
| Age Factors | 1 | 2015 | 2997 | 0.080 |
Why?
|
| Remission Induction | 1 | 2009 | 310 | 0.070 |
Why?
|
| Acceleration | 2 | 2019 | 30 | 0.070 |
Why?
|
| Hemolysis | 2 | 2021 | 114 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 337 | 0.070 |
Why?
|
| Creatinine | 1 | 2009 | 418 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 1419 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3172 | 0.060 |
Why?
|
| United States | 1 | 2021 | 11798 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1735 | 0.060 |
Why?
|
| Hospitalization | 2 | 2024 | 1919 | 0.060 |
Why?
|
| Chlorides | 1 | 2022 | 108 | 0.050 |
Why?
|
| Hirudins | 1 | 2022 | 40 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 471 | 0.050 |
Why?
|
| Antithrombins | 1 | 2022 | 61 | 0.050 |
Why?
|
| Transferrin | 1 | 2021 | 49 | 0.050 |
Why?
|
| Diuretics | 1 | 2022 | 168 | 0.050 |
Why?
|
| Thinness | 1 | 2021 | 77 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 308 | 0.040 |
Why?
|
| American Heart Association | 1 | 2023 | 329 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 228 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 3056 | 0.040 |
Why?
|
| Heparin | 1 | 2022 | 230 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 478 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2024 | 1100 | 0.040 |
Why?
|
| Iron | 1 | 2021 | 305 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 1436 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 519 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2021 | 468 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2018 | 165 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 507 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 832 | 0.040 |
Why?
|
| Biomarkers | 2 | 2018 | 3434 | 0.040 |
Why?
|
| End Stage Liver Disease | 1 | 2020 | 202 | 0.030 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 23 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1161 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1404 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2017 | 177 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 2016 | 60 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2021 | 1722 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 239 | 0.030 |
Why?
|
| Forensic Pathology | 1 | 2013 | 8 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1512 | 0.030 |
Why?
|
| Phenotype | 1 | 2023 | 4611 | 0.030 |
Why?
|
| Seizures | 1 | 2018 | 892 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2013 | 322 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2171 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2016 | 1006 | 0.020 |
Why?
|
| Pregnancy | 1 | 2017 | 7600 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 29430 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 36526 | 0.010 |
Why?
|